JOSHUA DEANE: Open Payments
NPI 1225080468 · ATASCADERO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,201 in 57 payments from 8 companies in 2025. Trend: 2023 $225 · 2024 $541 · 2025 $1,201
Food & beverage: $1,201
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $234 |
| Alkermes, Inc. | 12 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $190 |
| Janssen Pharmaceuticals, Inc | 4 | $182 |
| ABBVIE INC. | 14 | $172 |
| Teva Pharmaceuticals USA, Inc. | 4 | $96 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Lundbeck LLC | 2 | $30 |
Products named: COBENFY, ARISTADA, CAPLYTA, INVEGA SUSTENNA, VRAYLAR, UZEDY, ABILIFY ASIMTUFII, REXULTI.
Industry payments across CA — which companies pay providers there.
